Natixis Advisors
TMDX icon

Natixis Advisors’s Transmedics TMDX Stock Holding History

Natixis Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02M Sell
10,220
-1,803
-15% -$235K ﹤0.01% 1351
2025
Q4 		$1.46M Sell
12,023
-1,259
-9% -$158K ﹤0.01% 1145
2025
Q3 		$1.49M Sell
13,282
-1,533
-10% -$179K ﹤0.01% 1193
2025
Q2 		$1.99M Buy
+14,815
New +$1.63M ﹤0.01% 1084
2025
Q1 		– Sell
-62,687
Closed -$3.91M – 1682
2024
Q4 		$3.91M Sell
62,687
-15,386
-20% -$1.43M 0.01% 890
2024
Q3 		$12.3M Buy
78,073
+17,933
+30% +$2.76M 0.02% 603
2024
Q2 		$9.06M Buy
+60,140
New +$7.21M 0.02% 637

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Natixis Advisors's TMDX Position: Q1 2026 in Review

Natixis Advisors reduced its Transmedics (TMDX) stake by 15% in Q1 2026, selling an estimated $235K and leaving 10,220 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1351.

Natixis Advisors first reported a position in TMDX in Q2 2024 and has held it in 7 quarters since. The position peaked at $12.3M in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Natixis Advisors held 10,220 shares of Transmedics worth $1.02M as of Q1 2026.
  • Natixis Advisors sold 1,803 Transmedics shares in Q1 2026, an estimated $235K.
  • Transmedics made up ﹤0.01% of Natixis Advisors's portfolio in Q1 2026, its #1351 holding.
  • Natixis Advisors first reported a position in Transmedics in Q2 2024 and has held it in 7 quarters since.
  • Natixis Advisors's Transmedics position peaked at $12.3M in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Natixis Advisors's 13F filing for Q1 2026, filed 13 May 2026.